The back of the upper arm is accessible but may require help to reach
Over the past few years, litigation has focused on a wide range of issues including patent and other IP disputes, product liability, regulatory challenges, importation concerns, and legal issues concerning the availability of compounded versions of GLP-1 drugs in view of the U.S
Back Rehfeld, JF (March 2021) "Cholecystokinin and the hormone concept', Endocrine Connections , 10/3
Featured for Provider Access and Personalized Care The article highlights Independent Wellness as a leader in GLP-1 treatment due to its emphasis on continuity of care and direct provider access
GLP-1 medications were first tested and approved for type 2 diabetes
doi: 10.1016/S0140-6736(17)30069-7 25 Pi-SunyerXAstrupAFujiokaKGreenwayFHalpernAKrempfMet al